Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption

Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset

(2020) Sophie Steiner et al.   Frontiers in Immunology

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome

(2020) Nadja Scherbakov et al.   ESC Heart Failure

A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors

(2020) Klaus Wirth et al.   AUTOIMMUNITY REVIEWS

Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome

(2020) Hiroyuki Fujii et al.   JOURNAL OF NEUROIMAGING

Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning

(2019) Ashley R. Valdez et al.   Frontiers in Pediatrics

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

(2019) Lily Chu et al.   Frontiers in Pediatrics

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

(2019) Anand Padmanabhan et al.   JOURNAL OF CLINICAL APHERESIS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease

(2018) Franziska Sotzny et al.   AUTOIMMUNITY REVIEWS

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME

(2018) Carmen Scheibenbogen et al.   PLoS One

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

(2018) Otavio Cabral-Marques et al.   Nature Communications

Update on the use of immunoglobulin in human disease: A review of evidence

(2017) Elena E. Perez et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer

(2017) Peter C. Rowe et al.   Frontiers in Pediatrics

Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome

(2016) Madlen Loebel et al.   BRAIN BEHAVIOR AND IMMUNITY

Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study

(2016) Josephine Heine et al.   JOURNAL OF NEUROLOGY

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

(2015) Øystein Fluge et al.   PLoS One

Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension

(2013) Michael Dandel et al.   ATHEROSCLEROSIS SUPPLEMENTS

Long-term benefits of immunoadsorption in β1-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy

(2012) Michael Dandel et al.   EUROPEAN JOURNAL OF HEART FAILURE

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression

(2012) Michael Maes et al.   METABOLIC BRAIN DISEASE

Reduction of [11C](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor

(2012) Shigeyuki Yamamoto et al.   PLoS One

Myalgic encephalomyelitis: International Consensus Criteria

(2011) B. M. Carruthers et al.   JOURNAL OF INTERNAL MEDICINE

Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity

(2011) G. H. Stummvoll et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

(2011) Øystein Fluge et al.   PLoS One

Autoantibodies, Polymorphisms in the Serotonin Pathway, and Human Leukocyte Antigen Class II Alleles in Chronic Fatigue Syndrome

(2009) Oscar-Danilo Ortega-Hernandez et al.   Annals of the New York Academy of Sciences